Jane Street Group, LLC G1 Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$7.6 - $11.02 $11,400 - $16,530	-1,500 Reduced 6.76%	20,700 $157,000
Q4 2021 Feb 15, 2022	SELL	$10.16 - $16.17 $215,392 - $342,804	-21,200 Reduced 48.85%	22,200 $227,000
Q3 2021 Nov 16, 2021	SELL	$13.16 - $22.47 $655,368 - $1.12 Million	-49,800 Reduced 53.43%	43,400 $582,000
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $739,746 - $994,896	-37,800 Reduced 28.85%	93,200 $2.05 Million
Q1 2021 May 18, 2021	BUY	$17.58 - $32.59 $1.44 Million - $2.66 Million	81,700 Added 165.72%	131,000 $3.15 Million
Q4 2020 Feb 17, 2021	BUY	$10.99 - $20.4 $409,927 - $760,920	37,300 Added 310.83%	49,300 $887,000
Q3 2020 Nov 17, 2020	BUY	$11.55 - $23.75 $138,600 - $285,000	12,000 New	12,000 $139,000

3.71M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.